|
GLRX3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.501000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.983600E-01 |
| Normal-vs-Stage2 |
4.943600E-01 |
| Normal-vs-Stage3 |
4.323000E-01 |
| Normal-vs-Stage4 |
1.004630E-01 |
| Stage1-vs-Stage2 |
6.732000E-01 |
| Stage1-vs-Stage3 |
1.856380E-01 |
| Stage1-vs-Stage4 |
1.491010E-01 |
| Stage2-vs-Stage3 |
2.299400E-01 |
| Stage2-vs-Stage4 |
4.817400E-01 |
| Stage3-vs-Stage4 |
3.073600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.212800E-01 |
| Normal-vs-AfricanAmerican |
1.708390E-01 |
| Normal-vs-Asian |
7.996200E-01 |
| Caucasian-vs-AfricanAmerican |
2.446300E-02 |
| Caucasian-vs-Asian |
9.807800E-01 |
| AfricanAmerican-vs-Asian |
4.023200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.668200E-01 |
| Normal-vs-Female |
6.235600E-01 |
| Male-vs-Female |
9.443800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.241600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.091400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.788800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.672000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.406600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.360400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.530400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.256200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.224200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.702400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.477200E-01 |
| Normal-vs-Grade 2 |
3.457200E-01 |
| Normal-vs-Grade 3 |
6.809400E-01 |
| Normal-vs-Grade 4 |
2.706400E-01 |
| Grade 1-vs-Grade 2 |
9.427400E-01 |
| Grade 1-vs-Grade 3 |
3.821400E-01 |
| Grade 1-vs-Grade 4 |
6.129400E-01 |
| Grade 2-vs-Grade 3 |
1.355030E-01 |
| Grade 2-vs-Grade 4 |
5.818000E-01 |
| Grade 3-vs-Grade 4 |
1.622790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.421000E-01 |
| Normal-vs-ccB subtype |
7.667000E-01 |
| ccA subtype-vs-ccB subtype |
9.208400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.587400E-01 |
| Normal-vs-N1 |
1.728160E-01 |
| N0-vs-N1 |
2.235800E-01 |
|
|
